Xtant Debt Ratio from 2010 to 2024

XTNT Stock

USD 0.40 0.01 2.44%

Xtant Medical Debt Ratio yearly trend continues to be comparatively stable with very little volatility. Debt Ratio will likely drop to 0.23 in 2024. From the period from 2010 to 2024, Xtant Medical Debt Ratio quarterly data regression had r-value of (0.05) and coefficient of variation of 75.06. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

0.24493586

Current Value

0.23

Quarterly Volatility

0.5179739

Credit Downgrade

Yuan Drop

Covid

Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant Medical's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 53.7 M or Gross Profit of 34 M, as well as many indicators such as Price To Sales Ratio of 1.4, Dividend Yield of 0.0 or PTB Ratio of 2.49. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.

Check out the analysis of Xtant Medical Correlation against competitors.

Latest Xtant Medical's Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Xtant Medical Holdings over the last few years. It is Xtant Medical's Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xtant Medical's overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

Xtant Debt Ratio Regression Statistics

	Arithmetic Mean	0.69
	Geometric Mean	0.55
	Coefficient Of Variation	75.06
	Mean Deviation	0.41
	Median	0.42
	Standard Deviation	0.52
	Sample Variance	0.27
	Range	1.55
	R-Value	(0.05)
	Mean Square Error	0.29
	R-Squared	0
	Significance	0.86
	Slope	(0.01)
	Total Sum of Squares	3.76

Xtant Debt Ratio History

	2024	0.23
	2023	0.24
	2022	0.26
	2021	0.29
	2019	1.78
	2018	1.69
	2017	1.31

Other Fundumenentals of Xtant Medical Holdings

Cash Flow To Debt Ratio

Xtant Medical Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Current Deferred Revenue	Short Term Debt	Intangible Assets	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Net Tangible Assets	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital
Total Assets		0.0	0.76	-0.16	0.92	0.76	0.82	0.76	0.83	0.15	0.91	-0.42	0.75	0.92	0.9	-0.52	0.61	0.08	0.02	0.2	0.11
Total Stockholder Equity	0.0		-0.62	-0.24	-0.17	0.31	-0.52	0.29	-0.22	0.39	-0.01	-0.03	-0.64	-0.17	-0.26	0.81	-0.43	-0.69	0.52	0.03	0.5
Net Debt	0.76	-0.62		0.04	0.81	0.44	0.98	0.34	0.77	-0.11	0.73	-0.25	0.99	0.84	0.88	-0.92	0.74	0.5	-0.36	0.12	-0.28
Retained Earnings	-0.16	-0.24	0.04		-0.05	-0.46	-0.05	-0.65	-0.35	-0.39	0.18	0.52	0.02	-0.04	0.11	-0.33	0.04	0.83	-0.88	0.79	-0.66
Accounts Payable	0.92	-0.17	0.81	-0.05		0.72	0.87	0.64	0.77	-0.03	0.82	-0.44	0.8	0.88	0.87	-0.62	0.62	0.26	-0.15	0.3	0.02
Net Receivables	0.76	0.31	0.44	-0.46	0.72		0.56	0.77	0.61	0.18	0.6	-0.5	0.41	0.68	0.55	-0.09	0.25	-0.3	0.29	-0.01	0.45
Total Liab	0.82	-0.52	0.98	-0.05	0.87	0.56		0.44	0.83	-0.12	0.76	-0.36	0.98	0.88	0.9	-0.86	0.75	0.41	-0.3	0.11	-0.17
Total Current Assets	0.76	0.29	0.34	-0.65	0.64	0.77	0.44		0.67	0.29	0.46	-0.63	0.36	0.57	0.44	-0.02	0.26	-0.46	0.62	-0.19	0.62
Current Deferred Revenue	0.83	-0.22	0.77	-0.35	0.77	0.61	0.83	0.67		0.11	0.62	-0.46	0.78	0.72	0.84	-0.58	0.82	0.03	0.1	-0.01	0.07
Short Term Debt	0.15	0.39	-0.11	-0.39	-0.03	0.18	-0.12	0.29	0.11		0.08	-0.06	-0.16	0.09	0.03	0.27	-0.23	-0.53	0.49	-0.35	-0.03
Intangible Assets	0.91	-0.01	0.73	0.18	0.82	0.6	0.76	0.46	0.62	0.08		-0.16	0.71	0.89	0.9	-0.58	0.56	0.3	-0.28	0.39	-0.15
Common Stock	-0.42	-0.03	-0.25	0.52	-0.44	-0.5	-0.36	-0.63	-0.46	-0.06	-0.16		-0.27	-0.32	-0.19	0.05	-0.17	0.26	-0.29	0.28	-0.22
Long Term Debt	0.75	-0.64	0.99	0.02	0.8	0.41	0.98	0.36	0.78	-0.16	0.71	-0.27		0.83	0.87	-0.92	0.76	0.49	-0.34	0.1	-0.23
Property Plant Equipment	0.92	-0.17	0.84	-0.04	0.88	0.68	0.88	0.57	0.72	0.09	0.89	-0.32	0.83		0.9	-0.65	0.5	0.24	-0.18	0.18	-0.03
Good Will	0.9	-0.26	0.88	0.11	0.87	0.55	0.9	0.44	0.84	0.03	0.9	-0.19	0.87	0.9		-0.76	0.78	0.38	-0.31	0.35	-0.21
Net Tangible Assets	-0.52	0.81	-0.92	-0.33	-0.62	-0.09	-0.86	-0.02	-0.58	0.27	-0.58	0.05	-0.92	-0.65	-0.76		-0.72	-0.76	0.61	-0.25	0.51
Short Long Term Debt	0.61	-0.43	0.74	0.04	0.62	0.25	0.75	0.26	0.82	-0.23	0.56	-0.17	0.76	0.5	0.78	-0.72		0.37	-0.26	0.2	-0.24
Long Term Debt Total	0.08	-0.69	0.5	0.83	0.26	-0.3	0.41	-0.46	0.03	-0.53	0.3	0.26	0.49	0.24	0.38	-0.76	0.37		-0.93	0.65	-0.67
Capital Surpluse	0.02	0.52	-0.36	-0.88	-0.15	0.29	-0.3	0.62	0.1	0.49	-0.28	-0.29	-0.34	-0.18	-0.31	0.61	-0.26	-0.93		-0.64	0.77
Net Invested Capital	0.2	0.03	0.12	0.79	0.3	-0.01	0.11	-0.19	-0.01	-0.35	0.39	0.28	0.1	0.18	0.35	-0.25	0.2	0.65	-0.64		-0.28
Net Working Capital	0.11	0.5	-0.28	-0.66	0.02	0.45	-0.17	0.62	0.07	-0.03	-0.15	-0.22	-0.23	-0.03	-0.21	0.51	-0.24	-0.67	0.77	-0.28

Click cells to compare fundamentals

About Xtant Medical Financial Statements

Xtant Medical shareholders use historical fundamental indicators, such as Debt Ratio, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xtant Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Debt Ratio	0.24	0.23
Cash Flow To Debt Ratio	(0.42)	(0.44)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Xtant Debt Ratio from 2010 to 2024

Latest Xtant Medical's Debt Ratio Growth Pattern

Xtant Debt Ratio Regression Statistics

Xtant Debt Ratio History

Other Fundumenentals of Xtant Medical Holdings

Xtant Medical Debt Ratio component correlations

About Xtant Medical Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Xtant Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY